These compounds may interact with:
Bcl-2-like protein 1
Potentially involved in: cancer; vascular disease; neurodegenerative disease; toxic encephalopathy; adenoma; cryptorchidism; diabetes mellitus, experimental; diabetes mellitus, non-insulin-dependent; head and neck neoplasms; liver diseases; liver neoplasms, experimental; lung neoplasms; multiple myeloma; myocardial infarction; pancreatic neoplasm; stomach neoplasms; neurotoxicity syndromes; erectile dysfunction; hearing impairment; amyotrophic lateral sclerosis 1
Disease data sourced from Pharos.